Related Experiment Videos
Neonatal paroxysmal supraventricular tachycardia with hydrops
Pediatrics
|March 1, 1975
Summary
Aggressive management successfully treated a critically ill infant with paroxysmal supraventricular tachycardia and hydrops fetalis. Alternative therapies like procainamide or quinidine should be considered to prevent digitalis toxicity.
Area of Science:
- Neonatal medicine
- Pediatric cardiology
- Critical care
Background:
- Paroxysmal supraventricular tachycardia (PSVT) is a common cardiac arrhythmia in neonates.
- Hydrops fetalis, characterized by abnormal fluid accumulation, can be associated with fetal cardiac conditions.
- Effective management of these conditions in critically ill infants is crucial.
Purpose of the Study:
- To report a case of successful management of a neonate with both PSVT and hydrops fetalis.
- To highlight the importance of careful therapeutic choices in this complex clinical scenario.
Main Methods:
- A critically ill infant diagnosed with PSVT and hydrops fetalis underwent aggressive medical management.
- Treatment strategies were carefully monitored to assess efficacy and potential adverse effects.
Main Results:
- The infant demonstrated a positive response to the aggressive management approach.
- Digitalis therapy required careful titration to avoid toxicity, indicating a narrow therapeutic window.
Conclusions:
- Aggressive management can be effective for neonates presenting with PSVT and hydrops fetalis.
- Procainamide or quinidine represent viable alternative therapeutic options when digitalis toxicity is a concern.